FAST NEWS: CanSino’s revenue plunges as demand dries up for Covid vaccines
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Wednesday it recorded a net loss of 1.28 billion yuan ($176 million) in the first half of this year, reversing a 16.04…
FAST NEWS: CanSino’s Inhaled Covid Booster Gets China Green Light
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) announced on Sunday that China’s National Medical Products Administration (NMPA) have given emergency use authorization for its inhaled recombinant Covid-19 vaccine for use as…
Recent Articles
RELATED ARTICLES
-
Health Guard plans dual listing to fund HPV vaccine fight
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
FAST NEWS: CanSino’s quarterly revenue rises, but loss also widens
6185.HK 688185.SHG
-
Goldwind’s profit tumbles as China sales start to deflate
2208.HK 002202.SHE
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK
